In this YouTube explanatory segment, the speaker outlines how glucagon targets liver and adipose tissue, likening it to a heat‑seeking missile that seeks out the most harmful fat. They introduce myosteatosis—the accumulation of fat within muscle fibers—explaining that this intramuscular fat degrades muscle quality, reduces insulin sensitivity, and weakens strength. The core claim is that retatrutide aggressively clears these lipids from muscle, effectively “cleaning up” the marbling. The speaker argues that concerns about retatrutide causing muscle loss miss the point: whether one loses muscle or fat depends on personal behaviors such as resistance training, protein intake, and sustainable weight‑loss strategies. The overarching message is that the goal should be health improvement, not merely weight reduction.
